Atıf Formatları
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. KOCA Et Al. , "Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study," Journal of Oncology Pharmacy Practice , vol.27, no.3, pp.541-546, 2021

KOCA, S. Et Al. 2021. Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study. Journal of Oncology Pharmacy Practice , vol.27, no.3 , 541-546.

KOCA, S., BEŞİROĞLU, M., ÖZÇELİK, M., KARACA, M., BİLİCİ, M., HACIOĞLU, M. B., ... GÖKÖZ DOĞU, G.(2021). Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study. Journal of Oncology Pharmacy Practice , vol.27, no.3, 541-546.

KOCA, SİNAN Et Al. "Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study," Journal of Oncology Pharmacy Practice , vol.27, no.3, 541-546, 2021

KOCA, SİNAN Et Al. "Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study." Journal of Oncology Pharmacy Practice , vol.27, no.3, pp.541-546, 2021

KOCA, S. Et Al. (2021) . "Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study." Journal of Oncology Pharmacy Practice , vol.27, no.3, pp.541-546.

@article{article, author={SİNAN KOCA Et Al. }, title={Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study}, journal={Journal of Oncology Pharmacy Practice}, year=2021, pages={541-546} }